7 false false false false false false false false false false true false false false false false false No description of principal activity 2024-02-01 Sage Accounts Production Advanced 2024 - FRS102_2024 3,942 1,394 5,336 3,092 680 3,772 1,564 850 xbrli:pure xbrli:shares iso4217:GBP 09378269 2024-02-01 2025-01-31 09378269 2025-01-31 09378269 2024-01-31 09378269 2023-02-01 2024-01-31 09378269 2024-01-31 09378269 2023-01-31 09378269 bus:Director1 2024-02-01 2025-01-31 09378269 core:WithinOneYear 2025-01-31 09378269 core:WithinOneYear 2024-01-31 09378269 core:ShareCapital 2025-01-31 09378269 core:ShareCapital 2024-01-31 09378269 core:RetainedEarningsAccumulatedLosses 2025-01-31 09378269 core:RetainedEarningsAccumulatedLosses 2024-01-31 09378269 bus:SmallEntities 2024-02-01 2025-01-31 09378269 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 09378269 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 09378269 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09378269 bus:FullAccounts 2024-02-01 2025-01-31 09378269 core:ComputerEquipment 2024-02-01 2025-01-31 09378269 core:CommunicationNetworkEquipment 2024-02-01 2025-01-31 09378269 core:ComputerEquipment 2024-01-31 09378269 core:ComputerEquipment 2025-01-31
COMPANY REGISTRATION NUMBER: 09378269
Talk Therapy (UK) Limited
Filleted Unaudited Financial Statements
31 January 2025
Talk Therapy (UK) Limited
Financial Statements
Year ended 31 January 2025
Contents
Page
Balance sheet
1
Notes to the financial statements
3
Talk Therapy (UK) Limited
Balance Sheet
31 January 2025
2025
2024
Note
£
£
£
Fixed assets
Tangible assets
5
1,564
850
Current assets
Debtors
6
45,329
49,990
Cash at bank and in hand
19,769
13,787
--------
--------
65,098
63,777
Creditors: amounts falling due within one year
7
31,048
31,744
--------
--------
Net current assets
34,050
32,033
--------
--------
Total assets less current liabilities
35,614
32,883
Provisions
Taxation including deferred tax
391
213
--------
--------
Net assets
35,223
32,670
--------
--------
Talk Therapy (UK) Limited
Balance Sheet (continued)
31 January 2025
2025
2024
Note
£
£
£
Capital and reserves
Called up share capital
100
100
Profit and loss account
35,123
32,570
--------
--------
Shareholders funds
35,223
32,670
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 29 October 2025 , and are signed on behalf of the board by:
Miss L M C Scrivener
Director
Company registration number: 09378269
Talk Therapy (UK) Limited
Notes to the Financial Statements
Year ended 31 January 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6 Corunna Court, Corunna Road, Warwick, CV34 5HQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis and in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Current tax is recognised on taxable profit for the current and past periods. Deferred tax is recognised in respect of all timing differences at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
25% straight line
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 7 (2024: 8 ).
5. Tangible assets
Equipment
£
Cost
At 1 February 2024
3,942
Additions
1,394
-------
At 31 January 2025
5,336
-------
Depreciation
At 1 February 2024
3,092
Charge for the year
680
-------
At 31 January 2025
3,772
-------
Carrying amount
At 31 January 2025
1,564
-------
At 31 January 2024
850
-------
6. Debtors
2025
2024
£
£
Trade debtors
45,329
49,494
Other debtors
496
--------
--------
45,329
49,990
--------
--------
7. Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
441
130
Corporation tax
9,929
11,407
Social security and other taxes
2,471
3,178
Other creditors
18,207
17,029
--------
--------
31,048
31,744
--------
--------
8. Director's advances, credits and guarantees
During the year the director had an interest-free loan with the company. The loan is repayable on demand. At the start of the year the company owed her £13,197, and at the end of the year the company owed her £14,425.